Douglas S. King

Douglas S. King

Iowa State University

H-index: 39

North America-United States

About Douglas S. King

Douglas S. King, With an exceptional h-index of 39 and a recent h-index of 18 (since 2020), a distinguished researcher at Iowa State University,

His recent articles reflect a diverse array of research interests and contributions to the field:

P662 Discontinuation of biologic therapy in Inflammatory Bowel Disease: longer term outcomes

P741 Do gastroenterology services need published standards for provision of antenatal care in patients with Inflammatory Bowel Disease? A local evaluation of UK practice

Towards commercialization of graphene-based end-of-life sensors for fire-protective fabrics

Novel lyocell fibre from Alberta-grown hemp

P647 Outcomes following the use of vedolizumab first line versus second line in Ulcerative Colitis: a single centre experience

Douglas S. King Information

University

Position

Professor of Kinesiology

Citations(all)

8976

Citations(since 2020)

1237

Cited By

7830

hIndex(all)

39

hIndex(since 2020)

18

i10Index(all)

56

i10Index(since 2020)

32

Email

University Profile Page

Iowa State University

Google Scholar

View Google Scholar Profile

Top articles of Douglas S. King

Title

Journal

Author(s)

Publication Date

P662 Discontinuation of biologic therapy in Inflammatory Bowel Disease: longer term outcomes

Journal of Crohn's and Colitis

I Al-Talib

M Iqbal

J Slater

B Bates

J Jones

...

2024/1/1

P741 Do gastroenterology services need published standards for provision of antenatal care in patients with Inflammatory Bowel Disease? A local evaluation of UK practice

Journal of Crohn's and Colitis

M Tolan

J Nartey

M Dattoo

D King

S de Silva

2023/2/1

Towards commercialization of graphene-based end-of-life sensors for fire-protective fabrics

IOP Conference Series: Materials Science and Engineering

D Yehia

L Lawson

D King

HJ Chung

J Batcheller

...

2023

Novel lyocell fibre from Alberta-grown hemp

IOP Conference Series: Materials Science and Engineering

LM Degenstein

D King

L Lawson

W Chute

PI Dolez

2023

P647 Outcomes following the use of vedolizumab first line versus second line in Ulcerative Colitis: a single centre experience

Journal of Crohn's and Colitis

S Almas

I Al-Talib

C Rahman

M Ansari

J Jones

...

2023/2/1

See List of Professors in Douglas S. King University(Iowa State University)